Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares OutstandingShares OutstandingShort-Term Debt issuancesShort-Term Debt repayments
Ratios

China Pharma Holdings (CPHI) Leases (2018 - 2025)

China Pharma Holdings filings provide 8 years of Leases readings, the most recent being $181828.0 for Q4 2025.

  • On a quarterly basis, Leases rose 374.77% to $181828.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $181828.0, a 374.77% increase, with the full-year FY2025 number at $181828.0, up 374.77% from a year prior.
  • Leases hit $181828.0 in Q4 2025 for China Pharma Holdings, down from $197851.0 in the prior quarter.
  • In the past five years, Leases ranged from a high of $197851.0 in Q3 2025 to a low of $19176.0 in Q1 2025.
  • Median Leases over the past 5 years was $97006.0 (2024), compared with a mean of $97256.7.
  • Biggest five-year swings in Leases: tumbled 81.52% in 2023 and later soared 390.25% in 2024.
  • China Pharma Holdings' Leases stood at $127958.0 in 2021, then tumbled by 69.49% to $39046.0 in 2022, then skyrocketed by 198.65% to $116610.0 in 2023, then tumbled by 67.16% to $38298.0 in 2024, then surged by 374.77% to $181828.0 in 2025.
  • The last three reported values for Leases were $181828.0 (Q4 2025), $197851.0 (Q3 2025), and $19176.0 (Q1 2025) per Business Quant data.